ACNNF
Price:
$0.0038
Market Cap:
$2.55M
AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-02-10
Stock Exchange
PNK
Ticker
ACNNF
According to AusCann Group Holdings Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -0.13. This represents a change of -97.97% compared to the average of -6.23 of the last 4 quarters.
The mean historical PE Ratio of AusCann Group Holdings Ltd over the last ten years is -71.61. The current -0.13 PE Ratio has changed -82.31% with respect to the historical average. Over the past ten years (40 quarters), ACNNF's PE Ratio was at its highest in in the June 2010 quarter at 0. The PE Ratio was at its lowest in in the December 2015 quarter at -1128.62.
Average
-71.61
Median
-28.44
Minimum
-308.07
Maximum
-0.19
Discovering the peaks and valleys of AusCann Group Holdings Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 186.66%
Maximum Annual PE Ratio = -0.19
Minimum Annual Increase = -85.93%
Minimum Annual PE Ratio = -308.07
Year | PE Ratio | Change |
---|---|---|
2023 | -0.19 | -66.96% |
2022 | -0.57 | -85.93% |
2021 | -4.07 | -34.25% |
2020 | -6.20 | -52.60% |
2019 | -13.08 | -70.14% |
2018 | -43.80 | -7.59% |
2017 | -47.39 | -74.42% |
2016 | -185.25 | -39.87% |
2015 | -308.07 | 186.66% |
2014 | -107.47 | -40.14% |
The current PE Ratio of AusCann Group Holdings Ltd (ACNNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.61
5-year avg
-4.82
10-year avg
-71.61
AusCann Group Holdings Ltd’s PE Ratio is less than Amexdrug Corporation (216.50), greater than Aion Therapeutic Inc. (-2.88), less than Aspen Pharmacare Holdings Limited (14.48), greater than Antisense Therapeutics Limited (-6.27), greater than Alterola Biotech, Inc. (-5.04), greater than The BC Bud Corporation (-0.18), greater than Crescita Therapeutics Inc. (-4.08),
Company | PE Ratio | Market cap |
---|---|---|
216.50 | $338.82K | |
-2.88 | $2.39M | |
14.48 | $5.44B | |
-6.27 | $92.64M | |
-5.04 | $7.74M | |
-0.18 | $781.33K | |
-4.08 | $8.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AusCann Group Holdings Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AusCann Group Holdings Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AusCann Group Holdings Ltd's PE Ratio?
How is the PE Ratio calculated for AusCann Group Holdings Ltd (ACNNF)?
What is the highest PE Ratio for AusCann Group Holdings Ltd (ACNNF)?
What is the 3-year average PE Ratio for AusCann Group Holdings Ltd (ACNNF)?
What is the 5-year average PE Ratio for AusCann Group Holdings Ltd (ACNNF)?
How does the current PE Ratio for AusCann Group Holdings Ltd (ACNNF) compare to its historical average?